Skip to main content

Third Rock startup raises $60M for cancer trial, nabs former Celgene exec

Twenty years after helping to identify two of the key genes behind breast and ovarian cancer, oncologist and biotech executive Barbara Weber is now preparing for her company's first clinical trial of a cancer drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.